[Hiring] Senior Director, Communications, Public Affairs and Advocacy @Revolution Medicines

Role Description

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Reporting to the VP, General Manager, Germany, this individual is responsible for presenting RevMed amongst a broad variety of stakeholders, frequently interacting with them and communicating RevMed’s vision and mission. The Senior Director, Corporate Affairs transfers the regional corporate affairs strategy into the national market establishing RevMed as a credible and valued player and partner in the German market. The incumbent is accountable for achieved defined corporate affairs targets being supported by defined resources and investment budgets.

• Lead the German Corporate Affairs & Government Affairs organization, ensuring the successful execution of strategies.
• Serve as a key member of the German management team, partnering with cross-functional leaders to drive an integrated approach to Corporate Affairs, Market Access, and business priorities.
• Develop and execute a comprehensive corporate affairs strategy for Germany while contributing to European initiatives, advocating for policies that promote patient access, enhance stakeholder engagement, and strengthen RevMed’s position in the oncology landscape.
• Cultivate and maintain strategic relationships with government entities, healthcare providers, industry associations, and medical societies through innovative engagement programs.
• Partner with the Director, EAP and NPP, Europe on engagement strategies with patient advocacies.
• Represent RevMed in German healthcare policy forums and industry associations, collaborating with peers to shape collective positions and advocate for patient-centered policies.
• Drive cross-functional collaboration with RevMed’s German and European teams, ensuring alignment between German initiatives and broader organizational objectives.
• Identify and leverage strategic opportunities to enhance RevMed’s reputation and influence among key decision-makers and policy influencers.
• Manage the Corporate Affairs budget with strategic allocation of resources, select specialized agencies/vendors, and oversee project implementation.
• Develop stakeholder-centric communication strategies and consistent messaging frameworks that effectively communicate RevMed's vision, mission, and patient-centered approach.
• Monitor healthcare policy developments, provide strategic counsel to leadership, and ensure all activities comply with regulatory requirements and RevMed’s ethical standards.
• Lead and develop a team of Corporate Affairs professionals, providing strategic direction, mentorship, and fostering professional growth while ensuring alignment with organizational goals.

Qualifications

• 15+ years experience in Communications and/or Corporate Affairs, agency experience is advantageous.
• Minimum 8+ years of progressive experience in the pharmaceutical/biotech industry.
• Corporate Affairs roles, with strong scientific knowledge and understanding of healthcare/life sciences; formal degree desirable but not required for candidates with demonstrated expertise.
• Comprehensive understanding of the German healthcare system, reimbursement landscape, regulatory frameworks, and policy-making processes.
• Demonstrated expertise in stakeholder engagement, public affairs, and building corporate reputation in highly regulated healthcare environments.
• Proven track record of successfully influencing healthcare policy and stakeholder perspectives in competitive markets.
• Deep knowledge of the hemato-oncology landscape, key opinion leaders, and relevant industry associations.
• Strong strategic and analytical skills with ability to translate vision into actionable plans and navigate complex healthcare policy challenges.
• Successful experience in cross-functional collaboration within matrix organizations and fast-paced entrepreneurial environments.
• Exceptional communication, negotiation, and relationship-building capabilities with the ability to engage and influence senior stakeholders.
• Native German and excellent business English language skills required.
• Proficiency with MS Office and common business applications.
• Travel: Approximately 50% of time.

Company Description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

• Current clinical development includes daraxonrasib (RMC-6236), elironrasib (RMC-6291), zoldonrasib (RMC-9805), and RMC-5127.